| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.953 | 45.984 | 64.458 | 3.558 | 3.489 | 3.423 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 8.959 | 45.984 | 64.550 | 3.692 | 3.621 | 3.552 | 0 | 1 | 0 | 10.052 |
| Total Expenses - EUR | 14.533 | 54.885 | 49.655 | 13.696 | 13.431 | 13.176 | 3.419 | 6.782 | 1.176 | 4.599 |
| Gross Profit/Loss - EUR | -5.574 | -8.901 | 14.895 | -10.004 | -9.810 | -9.624 | -3.419 | -6.782 | -1.176 | 5.452 |
| Net Profit/Loss - EUR | -5.652 | -9.809 | 13.279 | -10.114 | -9.918 | -9.730 | -3.419 | -6.782 | -1.176 | 4.767 |
| Employees | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ace Pharma Cro International Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 12.710 | 24.366 | 12.561 | 9.290 | 9.110 | 8.938 | 5.802 | 0 | 0 | 0 |
| Current Assets | 125 | 5.569 | 7.192 | 3.453 | 3.386 | 3.322 | 3.562 | 3.174 | 3.299 | 12.134 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 23 | 0 | 141 | 3.248 | 3.185 | 3.124 | 3.102 | 3.146 | 3.252 | 11.962 |
| Cash | 102 | 5.569 | 7.052 | 205 | 201 | 198 | 460 | 28 | 48 | 172 |
| Shareholders Funds | -15.267 | -24.921 | -11.220 | -21.128 | -20.719 | -20.326 | -23.294 | -30.148 | -30.222 | -25.286 |
| Social Capital | 225 | 223 | 219 | 215 | 0 | 207 | 202 | 203 | 1.213 | 1.206 |
| Debts | 28.102 | 54.856 | 30.974 | 33.871 | 33.215 | 32.585 | 32.658 | 33.322 | 33.521 | 37.420 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7210 - 7210" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Ace Pharma Cro International Srl